These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20128003)

  • 21. [Adalimumab therapy in Crohn's disdease].
    Baryshnikov EN; Lazebnik LB; Parfenov AI
    Eksp Klin Gastroenterol; 2009; (5):92-8. PubMed ID: 20205331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies.
    Malesci A; Angelucci E; Bonifacio C; Sociale O; Omodei P; Repici A; Balzarini L; Danese S
    Inflamm Bowel Dis; 2009 Jun; 15(6):814-5. PubMed ID: 18831523
    [No Abstract]   [Full Text] [Related]  

  • 23. LDP-02 (Millenium).
    Marshall JK
    Curr Opin Investig Drugs; 2001 Apr; 2(4):502-4. PubMed ID: 11566006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J; Kucharzik T
    Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of Crohn disease--with special reference to anti-TNF antibody therapy].
    Takazoe M
    Nihon Naika Gakkai Zasshi; 2001 Dec; 90(12):2494-502. PubMed ID: 11917871
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inflammatory bowel disease: anti-TNF strategies and beyond].
    Hoffmann JC
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S76-8. PubMed ID: 15368175
    [No Abstract]   [Full Text] [Related]  

  • 27. Trastuzumab.
    Perez EA; Palmieri FM; Brock SM
    Cancer Treat Res; 2009; 151():181-96. PubMed ID: 19593513
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis.
    Riolo G; Towheed TE
    J Rheumatol; 2012 Jan; 39(1):192-4. PubMed ID: 22210682
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ; Camoglio L
    Pharm World Sci; 1997 Apr; 19(2):55-9. PubMed ID: 9151342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-TNF agents, the class of drugs that promotes treatment for Crohn disease].
    Michetti P
    Rev Med Suisse; 2008 Jan; 4(141):187-8. PubMed ID: 18335883
    [No Abstract]   [Full Text] [Related]  

  • 31. Are there predictors of Remicade treatment success or failure?
    Su C; Lichtenstein GR
    Adv Drug Deliv Rev; 2005 Jan; 57(2):237-45. PubMed ID: 15555740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide].
    Cabriada JL; García Sánchez V; Gomollón F; Hinojosa J; López San Román A; Mendoza JL; Mínguez M; Ricart E; Saro C
    Gastroenterol Hepatol; 2008 Dec; 31(10):693-7. PubMed ID: 19174086
    [No Abstract]   [Full Text] [Related]  

  • 33. [How long should combined therapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?].
    Domènech E; López San Román A; Garcia-Planella E
    Gastroenterol Hepatol; 2010; 33(6):471-2; author reply 472-3. PubMed ID: 20435379
    [No Abstract]   [Full Text] [Related]  

  • 34. [Certolizumab pegol--new possibilities in the treatment of Crohn's disease].
    Lazebnik LB; Kniazev OV
    Eksp Klin Gastroenterol; 2012; (3):100-5. PubMed ID: 22830233
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

  • 36. Distal esophageal involvement in Crohn disease: short treatment with adalimumab.
    Musto D; Martorelli L; Cirillo A; Selvaggi F; Esposito P; Russo MI; Riegler G
    Endoscopy; 2010; 42 Suppl 2():E299. PubMed ID: 21113880
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinically useful monoclonal antibodies in treatment.
    Drewe E; Powell RJ
    J Clin Pathol; 2002 Feb; 55(2):81-5. PubMed ID: 11864998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J
    Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infliximab 10 mg/kg every 3 weeks for Crohn's disease.
    Pillot C; Chevaux JB; Bigard MA; Peyrin-Biroulet L
    Am J Gastroenterol; 2010 Nov; 105(11):2509-10. PubMed ID: 21048692
    [No Abstract]   [Full Text] [Related]  

  • 40. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role?
    Kalemkerian G
    J Clin Oncol; 2005 Feb; 23(6):1325-6; author reply 1326-7. PubMed ID: 15718337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.